Origoni Massimo Professore associatoMedicineNMED/40

Biography

Publications

Biography

Born in Milano, on July 1, 1961

1986 – Graduate Medical Doctor, University Of Milano School of Medicine

1990 – Post Graduate Residency in Gynecology & Obstetrics, University of Milano School of Medicine

1994 – Assistant Professor in Gynecology & Obstetrics at the Department of Gynecology and Obstetrics of the University of Milano School of Medicine

1995 – Clinical Assistant Professor in Gynecology & Obstetrics at San Raffaele Scientific Institute, Milano

1998 – Confirmed Assistant Professor in Gynecology & Obstetrics at University of Milano School of Medicine

2001 – Enrolled as Assistant Professor in Gynecology & Obstetrics at Vita Salute San Raffaele University School of Medicine, Milano

2009 – Co-founder of the Italian HPV Study Group (IHSG)

2013 – Certified Associate Professor of Gynecology and Obstetrics

2017 – Associate Professor of Gynecology and Obstetrics at Vita Salute San Raffaele University School of Medicine, Milano.

Up today – Coordinator of the Gynecological Oncological Diagnostic Centre at San Raffaele Scientific Institute, Milano

Faculty of the Gynecology & Obstetrics teaching program at Vita Salute San Raffaele University School of Medicine

Faculty of the “Gynecology and Obstetrics” course within the International MD Program at Vita Salute San Raffaele University School of Medicine.

Coordinator of the Residency Program in Gynecology & Obstetrics at Vita Salute San Raffaele University School of Medicine

Coordinator of the Teaching Program in “Topographic and surgical anatomy of the female pelvis”

Coordinator of the Teaching Program in “Gynecological Oncology”

Coordinator of the Teaching program in “Diagnostic and Interventional Ultrasound in Gynecology & Obstetrics”.

Director: “Residential Advanced Course in Pathology and Clinics of the Lower Female Genital Tract” at Vita Salute San Raffaele University School of Medicine and Scientific Institute Ospedale San Raffaele, Milano.

Coordinator of the Activity Area “Teaching and Updating” at the Maternal Fetal Department of San Raffaele Scientific Institute

Member of International Scientific Societies in Gynecology & Obstetrics

Editorial Board Member of International Journals

Peer reviewer of International Journals

Citation Index: 1131

H-Index: 18 (last update 5/2017 Google Scholar)

 

 

RESEARCH FIELDS

Research fields of activity of Prof. M. Origoni are mainly focused upon the study of the neoplastic transformation of the lower female genital tract. In particular towards the correlation between Human PapillomaVirus (HPV) and female genital carcinogenesis.

 

 

 

 

 

 

 

 

Publications

PUBBLICAZIONI SELEZIONATE

Seresini S, Origoni M, Caputo L, Lillo F, Longhi R, Vantini S, Paganoni AM, Protti MP.

CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix. Immunology. 2010 Sep;131(1):89-98. Epub 2010 Jun 2.PMID: 20545782

 

Origoni M, Cavoretto P, Conti E, Ferrari A. Isolated tubal torsion in pregnancy.

Eur J Obstet Gynecol Reprod Biol. 2009 Oct;146(2):116-20. Epub 2009 Jun 2. Review.PMID: 19493607

 

Guaschino S, Benvenuti C; SOPHY Study Group. SOPHY project: an observational study of vaginal pH, lifestyle and correct intimate hygiene in women of different ages and in different physiopathological conditions. Part II. Minerva Ginecol. 2008 Oct;60(5):353-62. English, Italian. PMID: 18854801

 

Lillo F, Galli L, Lodini S, Taccagni G, Ferrari A, Origoni M. Extralesional detection and load of human papillomavirus DNA: a possible marker of preclinical tumor spread in cervical cancer.

J Low Genit Tract Dis. 2008 Jul;12(3):204-9.PMID: 18596462

 

Guaschino S, Benvenuti C; SOPHY Study Group. SOPHY project: an observational study of vaginal pH and lifestyle in women of different ages and in different physiopathological conditions. Part I. Minerva Ginecol. 2008 Apr;60(2):105-14. English, Italian. PMID: 18487960

 

Origoni M, Cavoretto P, Ferrari A. Acute isolated tubal torsion in pregnancy due to twisted Morgagni hydatid. Minerva Ginecol. 2008 Feb;60(1):95-6. No abstract available. PMID: 18277357

 

Seresini S, Origoni M, Lillo F, Caputo L, Paganoni AM, Vantini S, Longhi R, Taccagni G, Ferrari A, Doglioni C, Secchi P, Protti MP. IFN-gamma produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesions. J Immunol. 2007 Nov 15;179(10):7176-83.PMID: 17982110

 

Marelli G, Papaleo E, Origoni M, Caputo L, Ferrari A. Polyhexamethylene biguanide for treatment of external genital warts: a prospective, double-blind, randomized study.

Eur Rev Med Pharmacol Sci. 2005 Nov-Dec;9(6):369-72.PMID: 16479742

 

Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E, Taccagni G, Lazzarin A, Uberti-Foppa C. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

J Infect Dis. 2001 Sep 1;184(5):547-51. Epub 2001 Aug 9.PMID: 11494160

 

Origoni M, Rossi M, Ferrari D, Lillo F, Ferrari AG. Human papillomavirus with co-existing vulvar vestibulitis syndrome and vestibular papillomatosis. Int J Gynaecol Obstet. 1999 Mar;64(3):259-63.

 

Frigerio L, Mariani A, Gandini L, Origoni M, Galli L, Rabaiotti E, Aletti G, Ferrari A. Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy. Int Surg. 1998 Jul-Sep;83(3):265-70.PMID: 9870789

 

Uberti-Foppa C, Origoni M, Maillard M, Ferrari D, Ciuffreda D, Mastrorilli E, Lazzarin A, Lillo F. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women. J Med Virol. 1998 Oct;56(2):133-7.PMID: 9746069

 

Origoni M, Ferrari D, Rossi M, Gandini F, Sideri M, Ferrari A. Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet. 1996 Dec;55(3):259-64.PMID: 9003951

 

Doldi N, Origoni M, Bassan M, Ferrari D, Rossi M, Ferrari A. Vascular endothelial growth factor. Expression in human vulvar neoplastic and nonneoplastic tissues. J Reprod Med. 1996 Nov;41(11):844-8.PMID: 8951136

 

Origoni M, Dindelli M, Ferrari D, Frigerio L, Rossi M, Ferrari A. Surgical staging of invasive squamous cell carcinoma of the vulva. Analysis of treatment and survival. Int Surg. 1996 Jan-Mar;81(1):67-70.PMID: 8803710

 

Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet. 1994 Jul;46(1):53-6.PMID: 7805984 [

 

Parazzini F, La Vecchia C, Garsia S, Negri E, Sideri M, Rognoni MT, Origoni M. Determinants of invasive vulvar cancer risk: an Italian case-control study. Gynecol Oncol. 1993 Jan;48(1):50-5.PMID: 8423022

 

Origoni M, Sideri M, Garsia S, Carinelli SG, Ferrari AG. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol. 1992 Jun;45(3):313-6.PMID: 1612509

 

Origoni M, Dindelli M, Garsia S, Maggi R, Ferrari A. Spinocellular carcinoma of the vulva. Critical review of the surgical case histories from 1967-1989 Ann Ostet Ginecol Med Perinat. 1991 Mar-Apr;112(2):100-7. Italian. PMID: 1776775

 

Origoni M, Garsia S, Sideri M, Pifarotti G, Nicora M. Efficacy of topical oxatomide in women with pruritus vulvae. Drugs Exp Clin Res. 1990;16(11):591-6.PMID: 1983214

 

Sideri M, Rognoni M, Rizzolo L, Micheletti L, Barbero M, Origoni M, Garsia S. Antigens of the HLA system in women with vulvar lichen sclerosus. Association with HLA-B21. J Reprod Med. 1988 Jun;33(6):551-4.PMID: 3165465

 

Garsia S, Origoni M, Sideri M, Arnoletti E, Maggi R. Preneoplastic lesions of the vulva.

Eur J Gynaecol Oncol. 1988;9(4):342-5.PMID: 3391210

Il titolare del presente curriculum vitae, pubblicato online sul portale www.unisr.it, è garante in via esclusiva della correttezza e della veridicità dei dati e delle informazioni in esso riportate e del loro eventuale e puntuale aggiornamento. Egli è dunque il diretto ed unico responsabile dei contenuti indicati nei propri curricula.